CALN1 hypomethylation as a biomarker for high-risk bladder cancer

BACKGROUND: DNA methylation in cancer is considered a diagnostic and predictive biomarker. We investigated the usefulness of the methylation status of CALN1 as a biomarker for bladder cancer using methylation-sensitive restriction enzyme (MSRE)-quantitative polymerase chain reaction (qPCR). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Kimiaki, Naruse, Azumi, Akita, Kazutoshi, Muramatsu-Maekawa, Yuka, Kawase, Kota, Koie, Takuya, Horie, Masanobu, Kikuchi, Arizumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647952/
https://www.ncbi.nlm.nih.gov/pubmed/36352401
http://dx.doi.org/10.1186/s12894-022-01136-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647952/
https://www.ncbi.nlm.nih.gov/pubmed/36352401
http://dx.doi.org/10.1186/s12894-022-01136-y

Ejemplares similares